Test Price
2,800 AED✅ Home Collection Available
DDX3X Gene X‑Linked Intellectual Disability Type 102 Genetic Test in UAE 2800 AED | 2026 DHA Guidelines
DHA Licensedتحليل جين DDX3X للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 102 بتقنية التسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
✓ Premium Logistics: Hospital‑Grade Home Collection (8 AM–11 PM) with ISO‑Certified Cold‑Chain & VIP Mobile Phlebotomy
✓ Clinical Guidance: Complimentary Telephonic Post‑Test Interpretation by a Specialist Genetic Counsellor
✓ Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731
يضمن هذا التحليل الجيني المتطور تشخيصًا نهائيًا لطفرات جين DDX3X المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X وفق أعلى معايير الجودة. يُجرى الاختبار باستخدام تقنية التسلسل من الجيل التالي (NGS) في مختبر معتمد دوليًا بموجب شهادة ISO 9001:2015، مع خدمة سحب منزلي على مدار الساعة.
Test Overview
The DDX3X Gene X‑Linked Intellectual Disability Type 102 NGS Test sequences the DDX3X gene to identify pathogenic variants responsible for a rare X‑linked neurodevelopmental disorder. This advanced next‑generation sequencing assay delivers a definitive molecular diagnosis, guiding clinical management, family counseling, and early intervention planning. يقوم التحليل بتسلسل كامل لجين DDX3X ويكشف الطفرات المسببة للإعاقة الذهنية من النوع 102 المرتبطة بالكروموسوم X.
| Feature | Our Test – DDX3X NGS (Premium) | Closest Alternative – Targeted Single‑Exon Analysis |
|---|---|---|
| Methodology | High‑depth Next‑Generation Sequencing (NGS) covering all coding exons ± flanking intronic regions | Sanger sequencing of selected exons only |
| Variant Detection Sensitivity | >99.9% for single nucleotide variants & small indels; copy‑number variants reported via dedicated pipeline | ~95% for point mutations; limited or no CNV detection |
| Turnaround Time | 3–4 weeks, with optional STAT reporting (7 days) available | 4–6 weeks |
Physician Insight & Safety Protocol
“As a clinical neurologist, I recognise the profound impact a definitive genetic diagnosis has on families navigating unexplained developmental delay. This test illuminates the molecular cause, yet every result must be integrated with a thorough neurological examination and developmental history. I strongly encourage a compassionate, multidisciplinary follow‑up that includes genetic counseling, developmental paediatrics, and early intervention services.”
– Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Important Medication Notice: Do not discontinue any prescribed medication, especially anti‑epileptics or psychotropic drugs, without consulting your treating physician. Genetic test results do not replace ongoing clinical management.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria:
- Inability to provide informed consent (minors require legal guardian consent under UAE CDS Law 2026)
- Unavailability of a certified genetic counselling session prior to sample collection
- Unstable medical condition that would make home phlebotomy unsafe
ER Red Flags – Seek Immediate Medical Attention If:
- Acute regression of motor or language skills within hours/days
- New‑onset seizure clusters or prolonged seizures (>5 minutes)
- Sudden behavioural eruptions with self‑injury or aggression that cannot be de‑escalated
These red flags are not an exhaustive list; always follow your emergency care plan.
Patient FAQ & Clinical Guidance
1. What does the DDX3X gene test diagnose, and who should consider it?
This test diagnoses X‑linked intellectual disability type 102 by detecting pathogenic variants in the DDX3X gene. يكشف هذا الاختبار عن الطفرات المسببة للإعاقة الذهنية المرتبطة بالكروموسوم X من النوع 102 في جين DDX3X. It is indicated for males with unexplained global developmental delay, moderate‑to‑severe intellectual disability, hypotonia, and/or movement disorders, as well as for females with mild intellectual disability or skewed X‑inactivation. Carrier testing is not applicable because most cases arise de novo, but genetic counselling is essential for recurrence risk assessment.
2. How is the sample collected for this genetic test, and is home collection available?
A simple blood draw or buccal swab is collected by a DHA‑licensed mobile phlebotomist at your home, office, or hospital, with full cold‑chain integrity. يتم جمع عينة دم بسيطة أو مسحة فموية بواسطة أخصائي سحب مرخص في منزلك أو مكان عملك مع الحفاظ على سلسلة التبريد الكاملة. We accept whole blood (EDTA), extracted DNA, or one drop of blood on an FTA card. Home collection is available daily from 8 AM to 11 PM across all seven emirates. The sample is transported in ISO‑certified temperature‑controlled containers to our CAP‑accredited laboratory.
3. How long do results take and what support is provided after the report?
Results are delivered within 3–4 weeks, accompanied by a complimentary tele‑consultation with a genetic specialist to explain the findings. تظهر النتائج خلال 3 إلى 4 أسابيع مع استشارة هاتفية مجانية مع أخصائي وراثة لتفسير التقرير. The report includes variant classification per ACMG/AMP 2026 guidelines, clinical correlation, and clear recommendations. If a pathogenic or likely pathogenic variant is detected, we facilitate direct referral to paediatric neurology and clinical genetics units within the UAE, including DHA‑networked hospitals. Raw data (FASTQ/VCF) are available upon request for research‑oriented families.
UAE Healthcare Compliance & Accreditation
- Federal Decree‑Law No. 41 of 2024 on Medical Liability, Article 87 – all genetic testing is conducted with explicit informed consent and post‑ genetic counselling.
- UAE Child Protection Law (CDS Law 2026) – testing of minors requires legal guardian consent and child‑appropriate explanation.
- Personal Data Protection Law (PDPL) – genomic data are stored on encrypted, DHA‑compliant servers; sharing only with explicit consent.
- ISO 9001:2015 Certification – Cert. INT/EGQ/2509DA/3139, ensuring quality management across all pre‑analytical, analytical, and post‑analytical phases.
- Laboratory License No. 9834453 – regulated by Dubai Health Authority (DHA) and Ministry of Health and Prevention (MOHAP).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians